Buy or sell Cellworks stock pre IPO via an EquityZen fund
Cellworks is a life sciences technology company involved in drug and bio-marker discovery and researches in therapeutic areas.
About Cellworks Stock
Cellworks Group, Inc. operates as a life sciences technology company. The company provides iC-PHYS, a technology platform that enables drug and bio-marker discovery and research in focused therapeutic areas. The company provides disease focused drug discovery and research solutions in the areas of oncology, such as integrated tumor cell and endothelial cell with stromal inputs; inflammation diseases, such as macrophage, neutrophil, osteoclast, and T-cell; type-2 diabetes; infectious diseases; skin pigmentation and ageing; and neurodegenerative. The company was founded in 2005 and is based in Saratoga, California. It has a research and development facility in Bangalore, India.
Co-Founder & Chief Scientific Officer
Co-Founder & CEO
Co-Founder & President
The Best Things Come In Threes
TechCrunch - Sep, 15 2015